Health Care Innovation
Drug Innovation
ISSUE BRIEF: Nevada Proposal To Regulate Excess Costs Are Price Controls By Another Name
Click here to download a copy of PRI’s Issue Brief Senate Bill 265 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with drugs for diabetes, which are defined as the excess costs over the highest price in other developed countries. The Fiscal Notes on SB 265 ...
Commentary
The Good, The Bad, And The NICE: A Cautionary Tale For Government Negotiation
One of the cornerstones of Great Britain’s National Health Service is an agency that approves and controls access to prescription drugs, the National Institute for Health and Care Excellence. NICE recently announced a new policy that could delay and restrict access to new medicines for British citizens if the agency ...
California
Single Payer Is Fool’s Gold For California
While the latest Republican attempt to repeal and replace ObamaCare may have failed, Democrats in California and in D.C. are just getting started in their effort to eliminate the health law. Unfortunately, they’re angling to replace ObamaCare with something even worse. In California, State Senators Ricardo Lara and Toni Atkins ...
California
California Single-Payer Bill Looks Backward, Instead Of Forward To A New Era Of Patient Choice
Here we go again. The California State Legislature is considering yet another bill to impose a so-called single-payer, government monopoly, health care system. This has long been an obsession of the California’s nurses unions, because a health system under total government control would suit the narrow interests of union leaders. ...
Commentary
Oregon’s Drug Price Bill Is Hard To Swallow
President Donald Trump is not the only politician saying he is going to work to get drug prices down. Oregon lawmakers are already patting themselves on the back for tackling drug prices. Rep. Mitch Greenlick (D-Portland) says the measure, Oregon House Bill 2387, could be a model for national reform. ...
Drug Innovation
ISSUE BRIEF: Oregon Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Drug Innovation
Issue Brief: Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Commentary
Drug Importation Won’t Save Dollars Or Lives
A recent oped in The Hill by MedShadow Foundation founder Suzanne Robotti claims that permitting Americans to import prescription drugs from Canada would save dollars and lives. It would do neither. Prescription drug importation has several notable proponents, like Sens. John McCain (R-Ariz.), Amy Kobuchar (D-Minn.), and Bernie Sanders (I-Vt.), ...
Drug Pricing
Health Care Expert: If Obamacare Isn’t Immediately Repealed, Then It Likely Never Will Be
Ever since the Affordable Care Act — colloquially known as “Obamacare” — was signed into law in March 2010, the primary goal of congressional Republicans has been to repeal the law and replace it with a market-based solution that they say works for all Americans. For years, Republicans were only ...
Commentary
The New Senate’s Top Priority: Destroying Drug Innovation?
Minnesota Senator Amy Klobuchar just introduced a federal budget amendment that would legalize the importation of foreign prescription drugs. This particular policy change has long topped Democrats’ health care wish list, but shockingly, they might find support across the aisle this year, as President-elect Trump has spoken glowingly of importation. ...
ISSUE BRIEF: Nevada Proposal To Regulate Excess Costs Are Price Controls By Another Name
Click here to download a copy of PRI’s Issue Brief Senate Bill 265 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with drugs for diabetes, which are defined as the excess costs over the highest price in other developed countries. The Fiscal Notes on SB 265 ...
The Good, The Bad, And The NICE: A Cautionary Tale For Government Negotiation
One of the cornerstones of Great Britain’s National Health Service is an agency that approves and controls access to prescription drugs, the National Institute for Health and Care Excellence. NICE recently announced a new policy that could delay and restrict access to new medicines for British citizens if the agency ...
Single Payer Is Fool’s Gold For California
While the latest Republican attempt to repeal and replace ObamaCare may have failed, Democrats in California and in D.C. are just getting started in their effort to eliminate the health law. Unfortunately, they’re angling to replace ObamaCare with something even worse. In California, State Senators Ricardo Lara and Toni Atkins ...
California Single-Payer Bill Looks Backward, Instead Of Forward To A New Era Of Patient Choice
Here we go again. The California State Legislature is considering yet another bill to impose a so-called single-payer, government monopoly, health care system. This has long been an obsession of the California’s nurses unions, because a health system under total government control would suit the narrow interests of union leaders. ...
Oregon’s Drug Price Bill Is Hard To Swallow
President Donald Trump is not the only politician saying he is going to work to get drug prices down. Oregon lawmakers are already patting themselves on the back for tackling drug prices. Rep. Mitch Greenlick (D-Portland) says the measure, Oregon House Bill 2387, could be a model for national reform. ...
ISSUE BRIEF: Oregon Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Issue Brief: Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Drug Importation Won’t Save Dollars Or Lives
A recent oped in The Hill by MedShadow Foundation founder Suzanne Robotti claims that permitting Americans to import prescription drugs from Canada would save dollars and lives. It would do neither. Prescription drug importation has several notable proponents, like Sens. John McCain (R-Ariz.), Amy Kobuchar (D-Minn.), and Bernie Sanders (I-Vt.), ...
Health Care Expert: If Obamacare Isn’t Immediately Repealed, Then It Likely Never Will Be
Ever since the Affordable Care Act — colloquially known as “Obamacare” — was signed into law in March 2010, the primary goal of congressional Republicans has been to repeal the law and replace it with a market-based solution that they say works for all Americans. For years, Republicans were only ...
The New Senate’s Top Priority: Destroying Drug Innovation?
Minnesota Senator Amy Klobuchar just introduced a federal budget amendment that would legalize the importation of foreign prescription drugs. This particular policy change has long topped Democrats’ health care wish list, but shockingly, they might find support across the aisle this year, as President-elect Trump has spoken glowingly of importation. ...
